SUMMARY The association of HLA-A,B,C, DR polymorphisms and of Bf and GLO with coeliac disease was analysed in 100 Italian children. Primary involvement of HLA-DR3 and DR7 is apparent, while specificities of nearby loci are probably associated secondarily, because of linkage disequilibrium. Direct assessment of D/DR genotype through family studies and mixed lymphocyte cultures led to the recognition of two high risk genotypes DR3/3 and DR3/7, and of two lower risk genotypes DR3/X and DR7/X. The different weight of the HLA-dependent genetic factors is to some extent correlated with the clinical and immunological parameters, suggesting that the low-risk genotypes induce a milder expression of coeliac disease. Furthermore, other genetic factors, such as sex, appear to contribute to the penetrance of the disease, especially in the case of DR3/X and DR7/X. Both genetic and environmental factors contribute to the onset and to clinical progression of coeliac disease. The role of genetic factors has long been substantiated by a high concordance rate in monozygotic twins, and an increased incidence of overt malabsorption or of asymptomatic histological lesions in first-degree relatives.' 2 More recently, the association between markers of the HLA system and coeliac disease has provided new evidence of the importance of genetic factors in this disease. 8 Different genetic models have been put forward, which propose dominant or recessive expression of HLA-linked gene(s), or in addition assume the involvement of non-HLA gene(s).9 I() In susceptible individuals, exposure to dietary gluten, or to purified gliadin fractions under experimental conditions, is the leading known environmental factor. Clinical and/or histological improvement on a gluten-free diet and relapse after gluten challenge have thus been established as fixed diagnostic criteria.11 Nevertheless, the protean nature of the clinical picture is adequately shown by the significant proportion of atypical cases.'2 As part of an ongoing study, the present report (1) provides further evidence of the association of
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R2 MULTIWAY CONTINGENCY TABLES
The following approach was used because many of these specificities are interassociated by linkage disequilibrium. The observed distribution of two markers of different loci -for example, DR3 and B8 or BfFl -in patients and controls was compared with those expected from several models for complex interaction. First, the 'complete' model was Table 2a for DR3-B8 and 2b for DR3-BfFl. In both cases model C, based on the association between DR3 and disease + the linkage disequilibrium between DR3 and B8 or BfFl respectively, showed a good fit with the observed data. Interactions I1,3
(direct association between disease and B8 or BfFl) and 11.2,3 (the so-called 'haplotype effect'23) thus proved to be unnecessary, although they were not excluded (as shown by the good fit of model A). For the sake of simplicity, therefore, our analysis will be confined to the HLA-DR locus. The genotype frequencies of patients and controls were then compared using Woolf s formula ( Fig. 1) : genotypes 3/3 and 3/7 displayed high risks (12.2 and 8.5 respectively), whereas lower risks were found for the 3/X (RR = 3.5) and 7/X (RR = 1.5) genotypes (X = any allele other than 3 and 7). Among the 7/X, three apparent DR7 homozygotes were found (expected 2. 1, not significant). The X/X genotype showed a risk close to nil, as it was only represented by three patients, all of whom carried the DR4 allele.
R4 SEX
The overall sex ratio was 0.64, in agreement with other paediatric samples. Equal numbers of males and females were found in the high risk DR genotypes 3/3 and 3/7 (M/F = 1.05), while females were in excess in the low risk group 3/X (M/ F = 0.70) and even more so in the 7/X group (M/F = 026, p<0.05) ( 
CLINICAL PROGRESSION
(i) The length of time between first gluten introduction and appearance of clinical symptoms (free interval) was longer in the low risk group 7/X (233±296 days) than in the remaining DR3 positive genotypes (142.5±74 days, p<005), while these did not differ among themselves. (ii) In 36 patients the clinical symptoms at onset were atypical for coeliac disease (10 cases showed constipation, nine isolated failure to thrive, five dwarfism, four anorexia, four vomiting, two muscular hypotonia, one oedema, one intolerance to milk proteins). In boys this atypical onset was more common in the low risk 3/X and 7/X genotypes than in the high risk genotypes (Table 3) , while in girls it was not related to DR. In the remaining patients, IgA concentrations showed significant differences between disease stage, age, and DR genc-type (Table 4) : (i) IgA rose during the active stages of coeliac disease (first and third sample), and was lower during remission on gluten free diet. In later follow-up, patients who did not strictly adhere to the prescribed gluten free diet showed an increase of IgA concentrations, even in the absence of overt clinical relapse (N Ansaldi, unpublished). (ii) In the second sample, IgA concentrations were significantly lower in the DR3 positive patients than in the DR3 negatives. In contrast, no correlation with DR was found in the first sample at the onset of malabsorption, nor in the third sample after gluten challenge.
Discussion
The genetics of coeliac disease are probably multifactorial, as shown by classic studies in populations and families,24 25 by the wide variety of the clinical features,12 and by the existence of asymptomatic The dual association with DR3 and DR7 still represents the most stimulating result of HLA studies in coeliac disease. The original findings by Albert et al, 6 Betuel et al,7 and ourselves8 have been substantiated in several populations.28 The strength of association is higher for DR3 in northern countries, while that of DR7 is generally lower and limited to southern countries. In the present data, the different weight of DR3 and DR7 is supported by several findings: (i) DR3 is more strongly associated than DR7; (ii) only DR3 shows a gene-dose effect -that is, genotype 3/3 has a higher risk than 3/X; (iii) the contribution of DR7 is only evident in the presence of DR3, where it increases the risk of DR3 heterozygotes up to the level of DR3/3 homozygotes. The contribution of DR7 alone (7/7 and 7/X) is weaker, and not even statistically significant in the usual Woolf test; nevertheless, some risk can also be attributed to these genotypes when compared with X/X (Svejgaard and Ryder29); in fact they account for almost one-third of the patients.
The association with two DR alleles resembles that found in type I diabetes, which is associated with DR3 and DR4.29 30 Two genetic hypotheses can explain these findings. The first assumes an illness gene d, in linkage disequilibrium with both DR3 and DR7; a tentative candidate might be the supertypic specificity MB2, the product of a separate gene, distinct from the classic DR locus. Thomson and Bodmer's procedure, the expected genotype frequencies were calculated for the first two models; both were rejected, the dominant for an excess of dd and a defect of Dd, and the recessive for a defect of dd and an excess of Dd (Table 5) be explained why the same DR product, say DR3, is associated with a variety of diseases, and why these only appear in a limited proportion of individuals with the relevant DR antigen. The second hypothesis thus requires the identification of additional genetic or environmental risk factors.
SEX
Our data indicate that coeliac disease is more common in females. As both sexes were equally exposed to the known environmental risk factorsthat is, artificial feeding and early introduction of gluten -the difference may be attributed to a lower genetic threshold in females. This view is further supported when sex and HLA genotypes are considered jointly. In our sample, the M/F ratio progressively decreases from the high risk 3/3 and 3/7 to the low risk DR genotype 3/X, and even more to the 7/X. The simplest interpretation of this trend is that the penetrance of the low risk HLA genotypes is increased in the context of the susceptible female 'background'. A similar observation has been reported by Batchelor et al in drug induced SLE,34 where the female sex again acted as a risk factor, together with HLA-DR4 and lowacetylator phenotype.
PHENOTYPIC VARIABILITY
The significance of this complex genetic pattern can be evaluated by comparison with the well known variability of the clinical features of coeliac disease. The findings that most suggested a correlation with the weight of genetic factors were the longer free interval in the low risk DR7/X genotype, and the proportion of cases with atypical onset; this was more frequent in male DR3/X and 7/X patients, perhaps because a low risk conferred by both DR and sex can only induce coeliac disease when additional precipitating processes cause a nonspecific mucosal lesion and trigger the development of gluten sensitivity. Subjective evidence of this kind may be biased by uncontrolled environmental factors and inaccurate clinical records. These finding, therefore, require further substantiation. The suggestion, however, that patients with lower HLA-dependent risk may run a milder coeliac disease course is also supported by the laboratory and immunological data. In this respect the most significant finding is the high number of IEL in DR3 positive patients after gluten challenge; this may be responsible for the early appearance of their symptoms. These patients may have higher cell mediated reactivity against jejunal mucosa in the presence of gluten, as previously shown by Falchuck et al,27 who found more severe tissue damage in patients carrying HLA-B8 than in patients negative for this antigen, and by Cunningham-Rundles et al,35 who showed a higher in vitro response to gluten of peripheral lymphocytes from normal individuals positive for HLA-B8 or DR3.
Although variations in Ig concentrations have been described in coeliac disease, mainly for IgA and IgG,' the involvement of humoral immunity in its pathogenesis is less understood. The IgA system is obviously a candidate because of its role against foreign antigens at the mucosal barrier. The presence of five patients in our series with selective IgA deficiency confirms that susceptibility to coeliac disease may occasionally be due to an impaired barrier to gluten. A second, but not alternative, explanation is that IgA deficiency and coeliac disease derive from a common autoimmune mechanism, as suggested by their association with DR3, and by the increased risk in IgA deficiency of other DR3 associated diseases, such as type I diabetes,36 dermatitis herpetiformis, and SLE.
In the remaining patients, who are not deficient, serum concentrations of IgA increased during the active stages -that is, at the first and third biopsy. In contrast, the second sample probably came close to the individual 'normal' value. It is tempting to attribute the lower IgA concentrations of the DR3 positive patients to some mechanism in common with selective IgA deficiency, with impaired local defence in both cases. Estimation of pathological changes in IgA levels, however, is complicated by genetically controlled variations observed in the general population, and also by the physiological increase from birth until adolescence.38 Our findings therefore require substantiation from longitudinal studies of IgA levels on patients, healthy siblings, and unrelated controls of known HLA genotype.
